1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism
NCT ID: NCT05320042
Last Updated: 2022-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2022-02-14
2022-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
NCT05129124
Orientation Characteristics of Daily Disposable Toric Contact Lenses
NCT06069609
Kalifilcon A Toric Compared to Commercially Available Lenses
NCT06098937
Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses
NCT05129072
1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for Presbyopia
NCT05325931
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
kalifilcon A Daily Disposable Toric
kalifilcon A Daily Disposable Toric
kalifilcon A Daily Disposable Toric
kalifilcon A Daily Disposable Toric
Ultra for Astigmatism Contact Lenses
Ultra for Astigmatism Contact Lenses
Ultra for Astigmatism Contact Lenses
Ultra for Astigmatism Contact Lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
kalifilcon A Daily Disposable Toric
kalifilcon A Daily Disposable Toric
Ultra for Astigmatism Contact Lenses
Ultra for Astigmatism Contact Lenses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
3. Have no active ocular disease or allergic conjunctivitis.
4. Not be using any topical ocular medications.
5. Be willing and able to follow instructions.
6. Have signed a statement of informed consent.
Exclusion Criteria
2. Considered by the Investigator to not be a suitable candidate for participation.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Steffen
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch site 1
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ROC2-21-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.